The dual role of ferroptosis in pancreatic cancer: a narrative review

Abstract. Pancreatic ductal adenocarcinoma is the main cause of cancer-related mortality, with a lack of effective treatments and overall survival rates far lower than other solid cancers. This clinical challenge is related to late diagnosis as well as primary or acquired resistance to therapy-induc...

Full description

Bibliographic Details
Main Authors: Daolin Tang, Xin Chen, Paul B. Comish, Rui Kang
Format: Article
Language:English
Published: Wolters Kluwer Health/LWW 2021-06-01
Series:Journal of Pancreatology
Online Access:http://journals.lww.com/10.1097/JP9.0000000000000067
_version_ 1818736913672044544
author Daolin Tang
Xin Chen
Paul B. Comish
Rui Kang
author_facet Daolin Tang
Xin Chen
Paul B. Comish
Rui Kang
author_sort Daolin Tang
collection DOAJ
description Abstract. Pancreatic ductal adenocarcinoma is the main cause of cancer-related mortality, with a lack of effective treatments and overall survival rates far lower than other solid cancers. This clinical challenge is related to late diagnosis as well as primary or acquired resistance to therapy-induced apoptosis. Targeting nonapoptotic cell death pathways may provide alternative therapeutic strategies to overcome drug resistance. In particular, recent studies have suggested that ferroptosis, a type of iron-dependent nonapoptotic cell death, is a promising target for pancreatic ductal adenocarcinoma. Ferroptosis can be triggered by inhibiting or activating the redox or iron metabolism-related pathways, mediated by extrinsic/membrane transports (e.g., solute carrier family 7 member 11) or intrinsic/enzymes (e.g., glutathione peroxidase 4). Although the exact effector molecule remains obscure, reactive oxygen species-induced lipid peroxidation and subsequent plasma membrane damage appears to play a central role in mediating ferroptotic death. While treatment-induced ferroptosis is beneficial to suppress tumor growth, inflammation-related immunosuppression caused by ferroptotic damage may promote the occurrence of pancreatic ductal adenocarcinoma. In this review, we outline the latest knowledge about the regulation and function of ferroptosis in pancreatic tumorigenesis and therapy.
first_indexed 2024-12-18T00:44:42Z
format Article
id doaj.art-defbc94b055c498c9a0ff8554ff190d5
institution Directory Open Access Journal
issn 2096-5664
2577-3577
language English
last_indexed 2024-12-18T00:44:42Z
publishDate 2021-06-01
publisher Wolters Kluwer Health/LWW
record_format Article
series Journal of Pancreatology
spelling doaj.art-defbc94b055c498c9a0ff8554ff190d52022-12-21T21:26:47ZengWolters Kluwer Health/LWWJournal of Pancreatology2096-56642577-35772021-06-0142768110.1097/JP9.0000000000000067202106000-00003The dual role of ferroptosis in pancreatic cancer: a narrative reviewDaolin TangXin ChenPaul B. ComishRui KangAbstract. Pancreatic ductal adenocarcinoma is the main cause of cancer-related mortality, with a lack of effective treatments and overall survival rates far lower than other solid cancers. This clinical challenge is related to late diagnosis as well as primary or acquired resistance to therapy-induced apoptosis. Targeting nonapoptotic cell death pathways may provide alternative therapeutic strategies to overcome drug resistance. In particular, recent studies have suggested that ferroptosis, a type of iron-dependent nonapoptotic cell death, is a promising target for pancreatic ductal adenocarcinoma. Ferroptosis can be triggered by inhibiting or activating the redox or iron metabolism-related pathways, mediated by extrinsic/membrane transports (e.g., solute carrier family 7 member 11) or intrinsic/enzymes (e.g., glutathione peroxidase 4). Although the exact effector molecule remains obscure, reactive oxygen species-induced lipid peroxidation and subsequent plasma membrane damage appears to play a central role in mediating ferroptotic death. While treatment-induced ferroptosis is beneficial to suppress tumor growth, inflammation-related immunosuppression caused by ferroptotic damage may promote the occurrence of pancreatic ductal adenocarcinoma. In this review, we outline the latest knowledge about the regulation and function of ferroptosis in pancreatic tumorigenesis and therapy.http://journals.lww.com/10.1097/JP9.0000000000000067
spellingShingle Daolin Tang
Xin Chen
Paul B. Comish
Rui Kang
The dual role of ferroptosis in pancreatic cancer: a narrative review
Journal of Pancreatology
title The dual role of ferroptosis in pancreatic cancer: a narrative review
title_full The dual role of ferroptosis in pancreatic cancer: a narrative review
title_fullStr The dual role of ferroptosis in pancreatic cancer: a narrative review
title_full_unstemmed The dual role of ferroptosis in pancreatic cancer: a narrative review
title_short The dual role of ferroptosis in pancreatic cancer: a narrative review
title_sort dual role of ferroptosis in pancreatic cancer a narrative review
url http://journals.lww.com/10.1097/JP9.0000000000000067
work_keys_str_mv AT daolintang thedualroleofferroptosisinpancreaticcanceranarrativereview
AT xinchen thedualroleofferroptosisinpancreaticcanceranarrativereview
AT paulbcomish thedualroleofferroptosisinpancreaticcanceranarrativereview
AT ruikang thedualroleofferroptosisinpancreaticcanceranarrativereview
AT daolintang dualroleofferroptosisinpancreaticcanceranarrativereview
AT xinchen dualroleofferroptosisinpancreaticcanceranarrativereview
AT paulbcomish dualroleofferroptosisinpancreaticcanceranarrativereview
AT ruikang dualroleofferroptosisinpancreaticcanceranarrativereview